Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress.

Ruby M. van Stein,Simone N. Koole,Karolina Sikorska,Desmond P.J. Barton,Lewis Perrin,Donal J. Brennan,Oliver Zivanovic,Berit Jul Mosgaard,Anna Fagotti,Pierre Emmanuel Colombo,Valesca P. Retèl,Gabe S. Sonke,Willemien J. van Driel

Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress.

2020

Ruby M. van Stein
Simone N. Koole
Karolina Sikorska
Desmond P.J. Barton
Lewis Perrin
Donal J. Brennan
Oliver Zivanovic
Berit Jul Mosgaard
Anna Fagotti
Pierre Emmanuel Colombo
Valesca P. Retèl
Gabe S. Sonke
Willemien J. van Driel

TPS6100Background: The addition of Hyperthermic Intraperitoneal Chemotherapy (HIPEC) to interval cytoreductive surgery improves recurrence-free and overall survival in patients with FIGO stage III ...

Keywords:

cytoreductive surgery
Oncology
epithelial ovarian cancer
Hyperthermic intraperitoneal chemotherapy
Pathology
Internal medicine
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations